CIK: 1352851 - Address: 1603 Orrington Avenue, 13Th Floor, Evanston, IL 60201
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret112247-21-8-22-35-9
P%wins100100000033
S%ret112247-21-8-22-35-9
S%wins0010010010010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/18/24 16:12
1/16/24
CVIIChurchill Capital Corp VIIDEFinancAcqCoBlank ChecksMagnetar Financial LLCILTS.m-210.540001,517I
9/2/22 16:15
8/31/22
AJXGreat Ajax Corp.MDRlEstREITReal Estate Investment TrustsMagnetar Financial LLCILTS.d-48,46024.230-2,000-611,260I
7/28/22 16:13
7/26/22
AJXGreat Ajax Corp.MDRlEstREITReal Estate Investment TrustsMagnetar Financial LLCILTS.d-4,90724.530-200-63,260I
6/30/22 16:02
6/28/22
AJXGreat Ajax Corp.MDRlEstREITReal Estate Investment TrustsMagnetar Financial LLCILTS.d-19,92224.900-800-193,460I
6/22/22 20:25
6/17/22
AJXGreat Ajax Corp.MDRlEstREITReal Estate Investment TrustsMagnetar Financial LLCILTS.d-4,89624.480-200-44,260I
6/29/06 13:22
6/20/06
OPXAOpexa Therapeutics, Inc.TXHealthDrugPharmaceutical PreparationsMagnetar Financial LLCILTP.a69.50010668S227-20-7-20-33
6/29/06 13:22
6/26/06
OPXAOpexa Therapeutics, Inc.TXHealthDrugPharmaceutical PreparationsMagnetar Financial LLCILTS.a-367.970-5-1668S227-20-7-20-33
6/28/06 19:21
6/20/06
OPXAOpexa Therapeutics, Inc.TXHealthDrugPharmaceutical PreparationsMagnetar Financial LLCILTP69.50010668S257-22-8-23-36
6/28/06 19:21
6/26/06
OPXAOpexa Therapeutics, Inc.TXHealthDrugPharmaceutical PreparationsMagnetar Financial LLCILTS-367.970-5-1668S257-22-8-23-36

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact